Mnk targeting enhances vulnerability of medulloblastoma stem -like cancer cells to PI3K-pllOalpha inhibition

被引：0
|
作者：
Bell, Jonathan B.
Eckerdt, Frank
Ma, Quanhong
Clymer, Jessica R.
Goldman, Stewart
Hashizume, Rintaro
Platanias, Leonidas C.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-LB-009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-009
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Targeting Cancer Stem Cells With Combined Inhibition of MEK and STAT3 in Pancreatic Cancer
    Roberts, C.
    Vansaun, M.
    Lamichhane, P.
    Messaggio, F.
    Kovacs, K.
    Nagathihalli, N.
    Merchant, N.
    PANCREAS, 2016, 45 (10) : 1534 - 1535
  • [42] Nobiletin Enhances the Chemotherapeutic Efficacy of Docetaxel through Inhibition of PI3K/AKT and Induction of Apoptosis in Colon Cancer Cells
    Li, Changlu
    Zhang, Chunling
    Wang, Yanfei
    Ghidan, Alaa Yousef
    Babujanarthanam, Ranganathan
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (07): : 1478 - 1486
  • [43] Dual targeting of PI3K and mTOR results in synergistic growth inhibition in NSCLC cells
    Chao, Herta H.
    Zito, Christopher
    Jilaveanu, Lucia
    Anagnostou, Valsamo
    Rimm, David
    Bepler, Gerold
    Camp, Robert
    Kluger, Harriet M.
    CANCER RESEARCH, 2010, 70
  • [44] PI3K/Akt/mTOR signaling pathway in cancer stem cells
    Fath, Mohsen Karami
    Ebrahimi, Menooa
    Nourbakhsh, Ehsan
    Hazara, Ahmad Zia
    Mirzaei, Ali
    Shafieyari, Saba
    Salehi, Azadeh
    Hoseinzadeh, Mahsa
    Payandeh, Zahra
    Barati, Ghasem
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 237
  • [45] THERAPEUTIC TARGETING OF CLK2 AND PI3K/mTOR IN GLIOBLASTOMA STEM CELLS
    Park, Soon Young
    Dong, Jianwen
    Martinez-Ledesma, Emmanuel
    Piao, Yuji
    Verhaak, Roel
    Balasubramaniyan, Veerakumar
    de Groot, John
    NEURO-ONCOLOGY, 2017, 19 : 65 - 65
  • [46] Targeting Drug-Resistant Prostate Cancer with Dual PI3K/mTOR Inhibition
    Tang, K. D.
    Ling, Ming-Tat
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3048 - 3056
  • [47] Chelerythrine Inhibits Stemness of Cancer Stem-Like Cells of Osteosarcoma and PI3K/AKT/mTOR Signal
    Chen, Zhixing
    Yang, Hui
    Zhang, Qianlu
    Hu, Qiongying
    Zhao, Ziyi
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [48] Inhibition of phosphatidylinositol 3-kinase (PI 3K) enhances insulin effect on prenylation in endothelial cells
    Goalstone, ML
    Montagnani, M
    Golovchenk, I
    Quon, M
    Draznin, B
    DIABETES, 2001, 50 : A286 - A286
  • [49] Targeting cancer stem cells in serous ovarian carcinoma using RP6530, a dual PI3k δ/γ inhibitor
    Sneha, S.
    Nivetha, R.
    Nagare, R. P.
    Viswanadha, Srikant
    Vakkalanka, Swaroop
    Ganesan, T. S.
    CANCER RESEARCH, 2017, 77
  • [50] Inhibition of the PI3K p110α impairs cell survival, chemoresistance and invasion in human medulloblastoma cells
    Guerreiro, Ana
    Fattet, Sarah
    Shalaby, Tarek
    Grotzer, Michael A.
    Delattre, Olivier
    Arcaro, Alexandre
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3551S - 3552S
12345